Wegovy 1MG/0.5ML 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9QY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $126,756
Award facts
- Contract value 100% obligated
- $126,756.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $126,756.32 by the Defense Logistics Agency (DLA) on January 7, 2026, for the supply of Wegovy 1mg/0.5ml auto-injectors. The contract carries a firm fixed-price structure with an ultimate completion date of February 4, 2026, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide.
The DLA, as part of the Department of Defense, procures pharmaceuticals and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., maintains significant federal contract relationships across multiple therapeutic domains and demonstrates established capability in fulfilling government requirements for pharmaceutical distribution. The Wegovy product supplied under this order represents diabetes and weight management medication delivered through the company's established federal supply chain infrastructure serving defense and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FW9QY?
SPE2DR26FW9QY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FW9QY worth?
The government has obligated $126,756 on SPE2DR26FW9QY.
Is contract SPE2DR26FW9QY an order under another contract?
Yes. SPE2DR26FW9QY is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9QY competed?
The extent of competition for SPE2DR26FW9QY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award